Mosseri Marlio Charles 13D/13G Filings for Nuvectis Pharma, Inc. (NVCT)

Mosseri Marlio Charles 13D and 13G filings for Nuvectis Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-02-28
08:37 am
Purchase		2023-12-3113GNuvectis Pharma, Inc.
NVCT		Mosseri Marlio Charles2,595,000
15.000%		214,824increase
(+9.03%)		Filing
2023-01-09
10:19 am
Purchase		2022-12-3013GNuvectis Pharma, Inc.
NVCT		Mosseri Marlio Charles2,380,176
16.300%		977,620increase
(+69.70%)		Filing
2022-03-28
6:46 pm
Purchase		2022-03-2213GNuvectis Pharma, Inc.
NVCT		Mosseri Marlio Charles1,402,556
11.030%		1,402,556increase
(New Position)		Filing